Blog
This May marks my 20th year in practice here in England — and I honestly can't think of a better way to honor that milestone than by spending a day with the people who made it possible: you!
A recent legal judgment against Meta and YouTube has brought something important into the spotlight. A jury determined that these platforms were not simply providing content—but were intentionally designing systems to keep users engaged, even addicted, to what they were watching.
Why?
Because the longer we stay engaged, the more valuable our attention becomes. In order to market products and services to us, one thing has to happen first: 👉 We have to keep watching.
Over the past year, my shoulder surgery has been a tremendous success. My strength and mobility continue to improve, and I’m grateful for the skill of my surgeon and the technology that made it possible.
But recently, I began experiencing some unexpected symptoms that led me to take a deeper look at the “biodegradable” implants used in my repair—and what that term really means.
In this week’s blog, I share my personal experience,
GLP-1 medications have become one of the most talked-about tools for weight loss in modern healthcare. For many individuals, these drugs have felt like a long-awaited breakthrough. Weight comes off. Appetite decreases. Blood sugar stabilizes. People feel hopeful.
But every therapeutic intervention has physiological consequences.
GLP-1 agonists work by stimulating GLP-1 receptors in both the brain and the gastrointestinal tract. This leads to:
Increased insulin secretion